AlbireoPharma

Albireo is a biotechnology company that develops drugs that fulfill unmet medical needs in the gastrointestinal (GI) area and a pipeline of programs for underserved markets. The company is engaged on developing novel therapies that address unmet medical needs in the GI area. It is focused on generating considerable clinical data for lead programme in chronic constipation, and on progressing its pre-clinical assets into the clinic. The company is headquartered in Gothenburg, Sweden.

Street: 
Arvid Wallgrens
City: 
Gothenburg
Postcode: 
413 46
Federal State : 
Sweden
WebSite: 
www.albireopharma.com
Fax: 
46-31-820223

Company Index Score

Current Index Score Historical Index Score
  • AlbireoPharma currently scores 50 % in the index.
  • AlbireoPharma is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • AlbireoPharma is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets